热门出版物 - 学术资源搜索

h5 指数:49
h5 中位数:80

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#17 Virology

标题/作者	引用次数	年份
Restoring confidence in vaccines in the COVID-19 era P Verger, E Dubé Expert Review of Vaccines 19 (11), 991-993	190	2020
Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies E Dubé, D Gagnon, N MacDonald, A Bocquier, P Peretti-Watel, P Verger Expert Review of Vaccines 17 (11), 989-1004	181	2018
Impact of the Delta variant on vaccine efficacy and response strategies L Bian, Q Gao, F Gao, Q Wang, Q He, X Wu, Q Mao, M Xu, Z Liang Expert Review of Vaccines 20 (10), 1201-1209	174	2021
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations R Acevedo, X Bai, R Borrow, DA Caugant, J Carlos, M Ceyhan, ... Expert Review of Vaccines 18 (1), 15-30	155	2019
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? S Cooper, H van Rooyen, CS Wiysonge Expert Review of Vaccines 20 (8), 921-933	152	2021
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies L Bian, F Gao, J Zhang, Q He, Q Mao, M Xu, Z Liang Expert Review of Vaccines 20 (4), 365-373	152	2021
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials M Arbyn, L Xu Expert Review of Vaccines 17 (12), 1085-1091	142	2018
COVID-19 vaccine: where are we now and where should we go? S Soleimanpour, A Yaghoubi Expert Review of Vaccines 20 (1), 23-44	142	2021
Prospects for a MERS-CoV spike vaccine Y Zhou, S Jiang, L Du Expert Review of Vaccines 17 (8), 677-686	139	2018
A review of 65 years of human adenovirus seroprevalence FJD Mennechet, O Paris, AR Ouoba, S Salazar Arenas, SB Sirima, ... Expert Review of Vaccines 18 (6), 597-613	136	2019
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis JKH Lee, GKL Lam, T Shin, J Kim, A Krishnan, DP Greenberg, A Chit Expert Review of Vaccines 17 (5), 435-443	135	2018
Virus-like particle vaccines: immunology and formulation for clinical translation B Donaldson, Z Lateef, GF Walker, SL Young, VK Ward Expert Review of Vaccines 17 (9), 833-849	129	2018
Vaccination of healthcare workers: is mandatory vaccination needed? HC Maltezou, K Theodoridou, C Ledda, V Rapisarda, M Theodoridou Expert Review of Vaccines 18 (1), 5-13	114	2019
Current challenges for cancer vaccine adjuvant development WS Bowen, AK Svrivastava, L Batra, H Barsoumian, H Shirwan Expert Review of Vaccines 17 (3), 207-215	114	2018
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations J Sultana, G Mazzaglia, N Luxi, A Cancellieri, A Capuano, C Ferrajolo, ... Expert Review of Vaccines 19 (10), 919-936	101	2020
How can a global pandemic affect vaccine hesitancy? E Dubé, NE MacDonald Expert Review of Vaccines 19 (10), 899-901	100	2020
Immunological basis for enhanced immunity of nanoparticle vaccines HG Kelly, SJ Kent, AK Wheatley Expert Review of Vaccines 18 (3), 269-280	98	2019
Glycoconjugate vaccines: current approaches towards faster vaccine design F Micoli, L Del Bino, R Alfini, F Carboni, MR Romano, R Adamo Expert Review of Vaccines 18 (9), 881-895	92	2019
Progress on norovirus vaccine research: public health considerations and future directions CP Mattison, CV Cardemil, AJ Hall Expert Review of Vaccines 17 (9), 773-784	88	2018
Flagellin as a vaccine adjuvant B Cui, X Liu, Y Fang, P Zhou, Y Zhang, Y Wang Expert Review of Vaccines 17 (4), 335-349	86	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。